The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients
Rodney J. Scott(New South Wales Department of Health), Juul Wijnen(Memorial University of Newfoundland), Hans F. A. Vasen(Leiden University Medical Center), Cliff Meldrum(New South Wales Department of Health), Frederik J. Hes(Leiden University Medical Center), Tom van Wezel(Leiden University Medical Center), Daniel Barker(University of Newcastle Australia), Bente A. Talseth‐Palmer(New South Wales Department of Health), Allan D. Spigelman(Cancer Institute of New South Wales), Shantie Jagmohan–Changur(Leiden University), Eva Kristin Andreassen(University of Oslo), Carli M.J. Tops(State University of New York)
Cited by 13
Related Papers
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939